Patents by Inventor Reza Ahangari Cohan

Reza Ahangari Cohan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220411765
    Abstract: A truncated hyaluronan synthase (HAS) comprising an exemplary amino acid sequence having at least 95% identity with SEQ ID NO: 2. The truncated HAS may be encoded by an exemplary nucleic acid sequence set forth in SEQ ID NO: 3.
    Type: Application
    Filed: June 20, 2022
    Publication date: December 29, 2022
    Inventors: Malihe Keramati, Reza Ahangari Cohan, Parsa Parsian, Elnaz Afshari
  • Patent number: 11499145
    Abstract: A truncated and modified Serratiopeptidase or a variant thereof, and polynucleotides encoding the same. The truncated and modified Serratiopeptidase may have an amino acid sequence including amino acids 1 to 344, and amino acids 1 to 380 of SEQ ID NO: 1. The truncated and modified Serratiopeptidase may further include a first Cysteine (C) residue at a N-terminus of the truncated and modified Serratiopeptidase, substituted for at least one of Alanine 8 and Leucine 12 of SEQ ID NO: 1; and a second Cysteine residue at a C-terminus of the truncated and modified Serratiopeptidase, substituted for at least one of Valine 339 and Arginine 302 of SEQ ID NO: 1. The first and the second Cysteine residues may be adapted to form at least one disulfide bond including at least one of C8-C339, and C12-C302 disulfide bonds between the N-terminus and the C-terminus of the truncated and modified Serratiopeptidase.
    Type: Grant
    Filed: November 17, 2020
    Date of Patent: November 15, 2022
    Inventors: Vahideh Valizadeh, Maryam Rouhani, Dariush Norouzian, Reza Ahangari Cohan, Sara Mola Salehi
  • Publication number: 20210062174
    Abstract: A truncated and modified Serratiopeptidase or a variant thereof, and polynucleotides encoding the same. The truncated and modified Serratiopeptidase may have an amino acid sequence including amino acids 1 to 344, and amino acids 1 to 380 of SEQ ID NO: 1. The truncated and modified Serratiopeptidase may further include a first Cysteine (C) residue at a N-terminus of the truncated and modified Serratiopeptidase, substituted for at least one of Alanine 8 and Leucine 12 of SEQ ID NO: 1; and a second Cysteine residue at a C-terminus of the truncated and modified Serratiopeptidase, substituted for at least one of Valine 339 and Arginine 302 of SEQ ID NO: 1. The first and the second Cysteine residues may be adapted to form at least one disulfide bond including at least one of C8-C339, and C12-C302 disulfide bonds between the N-terminus and the C-terminus of the truncated and modified Serratiopeptidase.
    Type: Application
    Filed: November 17, 2020
    Publication date: March 4, 2021
    Applicants: Pasteur Institute of Iran
    Inventors: Vahideh Valizadeh, Maryam Rouhani, Dariush Norouzian, Reza Ahangari Cohan, Sara Mola Salehi